Corpus callosum index and long-term disability in multiple sclerosis patients (Q48286048)

10 February 2018

title

Corpus callosum index and long-term disability in multiple sclerosis patients (English)

1 reference

10 February 2018

0 references

Ozgür Yaldizli

1

1 reference

10 February 2018

Ramin Atefy

2

1 reference

10 February 2018

Achim Gass

3

1 reference

10 February 2018

Dietrich Sturm

4

1 reference

10 February 2018

Stephanie Glassl

5

1 reference

10 February 2018

Barbara Tettenborn

6

1 reference

10 February 2018

Norman Putzki

7

1 reference

10 February 2018

publication date

3 March 2010

1 reference

10 February 2018

published in

Journal of Neurology

1 reference

10 February 2018

volume

257

1 reference

10 February 2018

issue

8

1 reference

10 February 2018

page(s)

1256-1264

1 reference

10 February 2018

Evidence of early cortical atrophy in MS: relevance to white matter changes and disability

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5503-X

Brain atrophy in relapsing-remitting multiple sclerosis and secondary progressive multiple sclerosis: longitudinal quantitative analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5503-X

Abnormal corpus callosum: a sensitive and specific indicator of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5503-X

Defining the clinical course of multiple sclerosis: Results of an international survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5503-X

Disability and prognosis in multiple sclerosis: demographic and clinical variables important for the ability to walk and awarding of disability pension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5503-X

Corpus callosum and subcallosal-periventricular lesions in multiple sclerosis: detection with MR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5503-X

Gray and white matter volume changes in early RRMS: a 2-year longitudinal study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5503-X

Accumulation of hypointense lesions ("black holes") on T1 spin-echo MRI correlates with disease progression in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5503-X

Quantitative volumetric analysis of brain magnetic resonance imaging from patients with multiple sclerosis.

21 January 2018

1 reference

12 December 2020

Prognostic factors in a multiple sclerosis incidence cohort with twenty-five years of follow-up

1 reference

12 December 2020

Three dimensional MRI estimates of brain and spinal cord atrophy in multiple sclerosis

1 reference

12 December 2020

1 reference

12 December 2020

Measuring brain atrophy in multiple sclerosis

1 reference

12 December 2020

Brain atrophy in clinically early relapsing-remitting multiple sclerosis.

1 reference

12 December 2020

Cognition and the corpus callosum: verbal fluency, visuospatial ability, and language lateralization related to midsagittal surface areas of callosal subregions

1 reference

12 December 2020

Brain tissue volume changes in relapsing-remitting multiple sclerosis: correlation with lesion load

1 reference

12 December 2020

Evidence for progressive gray matter loss in patients with relapsing-remitting MS.

1 reference

12 December 2020

Correlating MRI and clinical disease activity in multiple sclerosis: relevance of hypointense lesions on short-TR/short-TE (T1-weighted) spin-echo images

1 reference

12 December 2020

Use of the brain parenchymal fraction to measure whole brain atrophy in relapsing-remitting MS. Multiple Sclerosis Collaborative Research Group

1 reference

12 December 2020

Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process

1 reference

12 December 2020

Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis. US National MS Society Task Force.

1 reference

12 December 2020

The relationship between whole brain volume and disability in multiple sclerosis: a comparison of normalized gray vs. white matter with misclassification correction

1 reference

12 December 2020

A semiautomated measure of whole-brain atrophy in multiple sclerosis

1 reference

12 December 2020

Brain atrophy in relapsing-remitting multiple sclerosis: fractional volumetric analysis of gray matter and white matter

1 reference

12 December 2020

Correlation of magnetization transfer ratio with clinical disability in multiple sclerosis

1 reference

12 December 2020

Progression of non-age-related callosal brain atrophy in multiple sclerosis: a 9-year longitudinal MRI study representing four decades of disease development.

1 reference

12 December 2020

Ventricular enlargement in MS: one-year change at various stages of disease

1 reference

12 December 2020

Magnetic resonance imaging measures of brain atrophy in multiple sclerosis

1 reference

12 December 2020

Whole-brain atrophy in multiple sclerosis measured by automated versus semiautomated MR imaging segmentation

1 reference

12 December 2020

Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

1 reference

12 December 2020

Progressive grey matter atrophy in clinically early relapsing-remitting multiple sclerosis

1 reference

12 December 2020

Corpus callosum index: a practical method for long-term follow-up in multiple sclerosis

1 reference

12 December 2020

Spinal cord MRI using multi-array coils and fast spin echo. II. Findings in multiple sclerosis

1 reference

12 December 2020

Progressive cerebral atrophy in MS: a serial study using registered, volumetric MRI

1 reference

12 December 2020

Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance

1 reference

12 December 2020

Atrophy is detectable within a 3-month period in untreated patients with active relapsing remitting multiple sclerosis

1 reference

12 December 2020

Longitudinal brain volume measurement in multiple sclerosis: rate of brain atrophy is independent of the disease subtype

1 reference

12 December 2020

Brain atrophy and lesion load in a large population of patients with multiple sclerosis

1 reference

12 December 2020

Serial gadolinium-enhanced magnetic resonance imaging scans in patients with early, relapsing-remitting multiple sclerosis: Implications for clinical trials and natural history

1 reference

12 December 2020

Mechanisms of action of disease-modifying agents and brain volume changes in multiple sclerosis

1 reference

12 December 2020

The role of magnetic resonance techniques in understanding and managing multiple sclerosis

1 reference

12 December 2020

Quantitative pathological evidence for axonal loss in normal appearing white matter in multiple sclerosis

1 reference

12 December 2020

Evolution of different MRI measures in patients with active relapsing-remitting multiple sclerosis over 2 and 5 years: a case-control study

1 reference

12 December 2020

Progressive cerebral atrophy in multiple sclerosis. A serial MRI study

1 reference

12 December 2020

Functional correlates of callosal atrophy in relapsing-remitting multiple sclerosis patients. A preliminary MRI study

1 reference

12 December 2020

A spinal cord MRI study of benign and secondary progressive multiple sclerosis

1 reference

12 December 2020

Whole-brain T1 mapping in multiple sclerosis: global changes of normal-appearing gray and white matter.

1 reference

12 December 2020

A longitudinal study of callosal atrophy and interhemispheric dysfunction in relapsing-remitting multiple sclerosis.

1 reference

12 December 2020

Brain and spinal cord abnormalities in multiple sclerosis. Correlation between MRI parameters, clinical subtypes and symptoms

1 reference

12 December 2020

Correlations between changes in disability and T2-weighted brain MRI activity in multiple sclerosis: a follow-up study

1 reference

12 December 2020

Macroscopic and microscopic assessments of disease burden by MRI in multiple sclerosis: relationship to clinical parameters

1 reference

12 December 2020

10.1007/S00415-010-5503-X

Identifiers

DOI

1 reference

10 February 2018

release_3vovleg3dvckrmnuuonrrwlmqy

Fatcat ID

0 references

1 reference

10 February 2018